Jay Glazer’s ADHD story

As a TV personality, Jay talks passionately about 2 things: football and living with ADHD. Jay shares his story of struggling with symptoms, getting diagnosed as an adult, and finding the right treatment with non-stimulant Qelbree.

Jay Glazer is a real Qelbree patient and compensated ambassador. Rosie Glazer is a paid partner in this campaign and is not a Qelbree patient.
Decorative
Components

Jay Glazer’s Story: Managing an ADHD Diagnosis

Finding treatment to tackle his ADHD symptoms was a real challenge, until Jay discovered Qelbree.
Components

Sharing their ADHD story of building a strong, supportive team

Content Block Description

Jay and Rosie Glazer’s wedding day was nearly washed out by rain before a little faith and two beautiful rainbows saved the day. The moment serves as a metaphor for Jay’s life. He weathered a storm of inattention and impulsivity before getting diagnosed with ADHD in college, then struggled for many years to find both acceptance and a treatment that worked.

Yet with Rosie’s support and the start of treatment with Qelbree, those dark clouds soon cleared away.

As a TV personality and sports reporter, Jay needs to react quickly and calmly with the cameras rolling. He tried several stimulant therapies to manage his ADHD symptoms, but nothing clicked until non-stimulant Qelbree.

Once-a-day Qelbree is also a big win for Jay’s relationship with Rosie, helping him be more present, connected, and focused on what matters most.

Together, they advocate passionately for mental health and ADHD awareness, speaking openly about their story and encouraging others to do the same. The goal: Build one strong team that supports each other at every step of the ADHD journey.

Speedbump Icon

Finding the right treatment can take time

Speedbump Description
Getting diagnosed with ADHD is often a life-altering moment, and it can also feel like a huge relief. It did for Jay—yet it still took many years and several tries to find a treatment option that worked for his ADHD symptoms. With ADHD, patience is your best teammate.
Text
I’ve realized that I can have a healthy fulfilling relationship while managing my ADHD, and that has been a huge relief.”
Jay Glazer
Author descriptor HTML

TV personality with ADHD

Paid spokesperson for Qelbree

CTA Button
Multiple Card Cards
Single Card Icon or Image

See more ADHD stories

See the difference Qelbree is making in helping real people manage their ADHD.
Single Card CTA Button
Single Card Icon or Image

Share your story

Share your experience of navigating ADHD with Qelbree.
Single Card CTA Button
Single Card Icon or Image

ADHD and gender

Did you know that ADHD can look different in women and men?
Single Card CTA Button

Connect with the Qelbree community

Follow Qelbree on social media for updates.

IMPORTANT SAFETY INFORMATION ABOUT QELBREE

INDICATION

Qelbree® (viloxazine extended-release capsules) is a prescription medicine used to treat Attention-Deficit/Hyperactivity Disorder (ADHD) in adults and children 6 years and older.

IMPORTANT SAFETY INFORMATION
Qelbree may increase suicidal thoughts and actions, in children and adults with ADHD, especially within the first few months of treatment [read more] or when the dose is changed. Tell your doctor if you or your child have (or if there is a family history of) suicidal thoughts or actions before starting Qelbree. Monitor your or your child’s moods, behaviors, thoughts, and feelings during treatment with Qelbree. Report any new or sudden changes in these symptoms right away.

IMPORTANT SAFETY INFORMATION
Qelbree may increase suicidal thoughts and actions, in children and adults with ADHD, especially within the first few months of treatment or when the dose is changed. [read more] Tell your doctor if you or your child have (or if there is a family history of) suicidal thoughts or actions before starting Qelbree. Monitor your or your child’s moods, behaviors, thoughts, and feelings during treatment with Qelbree. Report any new or sudden changes in these symptoms right away.

You should not take Qelbree if you or your child:
Take a medicine for depression called a monoamine oxidase inhibitor (MAOI) or have stopped taking an MAOI in the past 14 days. Also, you or your child should avoid alosetron, duloxetine, ramelteon, tasimelteon, tizanidine, and theophylline.

Qelbree can increase blood pressure and heart rate. Your or your child’s doctor will monitor these vital signs.

Qelbree may cause manic episodes in patients with bipolar disorder. Tell your doctor if you or your child show any signs of mania.

Do not drive or operate heavy machinery until you know how Qelbree will affect you or your child. Qelbree may cause you or your child to feel sleepy or tired.

The most common side effects of Qelbree in patients 6 to 17 years are sleepiness, not feeling hungry, feeling tired, nausea, vomiting, trouble sleeping, and irritability, and in adults, insomnia, headache, sleepiness, tiredness, nausea, decreased appetite, dry mouth, and constipation. These are not all the possible side effects of Qelbree.

You are encouraged to report negative side effects of prescription drugs to the FDA. Visit www.fda.gov/medwatch or call 1-800-FDA-1088.

Please see Medication Guide, including Boxed Warning.

IMPORTANT SAFETY INFORMATION ABOUT QELBREE

INDICATION

Qelbree® (viloxazine extended-release capsules) is a prescription medicine used to treat Attention-Deficit/Hyperactivity Disorder (ADHD) in adults and children 6 years and older.

IMPORTANT SAFETY INFORMATION
Qelbree may increase suicidal thoughts and actions, in children and adults with ADHD, especially within the first few months of treatment [read more] or when the dose is changed. Tell your doctor if you or your child have (or if there is a family history of) suicidal thoughts or actions before starting Qelbree. Monitor your or your child’s moods, behaviors, thoughts, and feelings during treatment with Qelbree. Report any new or sudden changes in these symptoms right away.

IMPORTANT SAFETY INFORMATION
Qelbree may increase suicidal thoughts and actions, in children and adults with ADHD, especially within the first few months of treatment or when the dose is changed. [read more] Tell your doctor if you or your child have (or if there is a family history of) suicidal thoughts or actions before starting Qelbree. Monitor your or your child’s moods, behaviors, thoughts, and feelings during treatment with Qelbree. Report any new or sudden changes in these symptoms right away.

You should not take Qelbree if you or your child:
Take a medicine for depression called a monoamine oxidase inhibitor (MAOI) or have stopped taking an MAOI in the past 14 days. Also, you or your child should avoid alosetron, duloxetine, ramelteon, tasimelteon, tizanidine, and theophylline.

Qelbree can increase blood pressure and heart rate. Your or your child’s doctor will monitor these vital signs.

Qelbree may cause manic episodes in patients with bipolar disorder. Tell your doctor if you or your child show any signs of mania.

Do not drive or operate heavy machinery until you know how Qelbree will affect you or your child. Qelbree may cause you or your child to feel sleepy or tired.

The most common side effects of Qelbree in patients 6 to 17 years are sleepiness, not feeling hungry, feeling tired, nausea, vomiting, trouble sleeping, and irritability, and in adults, insomnia, headache, sleepiness, tiredness, nausea, decreased appetite, dry mouth, and constipation. These are not all the possible side effects of Qelbree.

You are encouraged to report negative side effects of prescription drugs to the FDA. Visit www.fda.gov/medwatch or call 1-800-FDA-1088.

Please see Medication Guide, including Boxed Warning.